Preimplantation paternal effects of acrylamide treatment on development and micronuclei formation in mice

Journal Article · Wed Oct 01 04:00:00 EDT 1997 · Environmental and Molecular Mutagenesis

OSTI ID:530869

Titenko-Holland, N; Shang, N; Smith, M T ^[1]

---

1. Univ. of California, Berkeley, CA (United States); and others

Treatment of male mice with acrylamide (AA, 50 mg/kg, 5 days) at postmeiotic stages of spermatogenesis was used to assess paternally mediated developmental and genetic toxicity in preimplantation embryos. There was a significant increase in the proportion of morphologically abnormal embryos (88.7 v 14.8%). The proliferation of morphologically normal embryos was significantly delayed, size of nuclei and number of cells were decreased, and fragmented nuclei were found in the majority of abnormal embryos (P<0.001). Cytogenetic damage was determined by the presence of micronuclei (MN) stained with DAPI or FISH with a pancentromeric probe. AA caused 10- and 20-fold increases in cells with MN in morphologically normal and abnormal embryos, respectively (41 and 93 MN per 1000 cells). There were no detectable effects of AA on size or ratio of centromere-positive MN. The presence of MN was not associated with the number or size of cells in the embryos. These findings suggest that multiple mechanisms are involved in male-mediated developmental and genetic toxicity of AA on preimplantation stages of embryogenesis. Future studies are needed to establish how preimplantation defects contribute to postimplantation and postnatal abnormalities.

• DOE Contract Number: W-7405-ENG-48
• OSTI ID: 530869
• Report Number(s): CONF-9704100--
• Journal Information: Environmental and Molecular Mutagenesis, Journal Name: Environmental and Molecular Mutagenesis Journal Issue: Suppl.28 Vol. 29; ISSN 0893-6692; ISSN EMMUEG
• Country of Publication: United States
• Language: English

Related Subjects

56 BIOLOGY AND MEDICINE
APPLIED STUDIES
ACRYLAMIDE
BIOLOGICAL EFFECTS
CONGENITAL MALFORMATIONS
MICE